National Clinical Care Commission Act

Bill 114 hr 1192, also known as the National Clinical Care Commission Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to establish a National Clinical Care Commission, which would be responsible for improving the coordination and quality of clinical care for individuals with complex metabolic or autoimmune diseases.

The Commission would be composed of experts in various fields related to clinical care, including healthcare providers, researchers, and patient advocates. Its main duties would include conducting a comprehensive review of the current state of clinical care for individuals with complex metabolic or autoimmune diseases, identifying gaps in care, and developing recommendations for improving care coordination and quality.

Additionally, the Commission would be required to submit a report to Congress outlining its findings and recommendations, as well as any legislative or regulatory changes that may be necessary to improve clinical care for individuals with these diseases. Overall, the National Clinical Care Commission Act aims to address the challenges faced by individuals with complex metabolic or autoimmune diseases in accessing high-quality clinical care. By establishing a dedicated Commission to focus on these issues, the bill seeks to improve outcomes and quality of life for these individuals.